NCT00258908View on ClinicalTrials.gov

Immunogenicity and Safety of ADACEL™ as Fifth Dose in Taiwan

PHASE3CompletedINTERVENTIONAL
Enrollment

115

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

August 31, 2006

Study Completion Date

August 31, 2006

Conditions
DiphtheriaTetanusPertussis
Interventions
BIOLOGICAL

Diphteria, tetanus, and Acellular Pertussis vaccine

0.5 mL, Intramuscular

Trial Locations (1)

Unknown

Taipei

All Listed Sponsors
lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY

NCT00258908 - Immunogenicity and Safety of ADACEL™ as Fifth Dose in Taiwan | Biotech Hunter | Biotech Hunter